الفهرس 
coverEnglishOnly 14 pages are availabe for public view
 |  | from | 141 |  |  |
| | | from | 141 | | |
Abstract
Viral Hepatitis - Pediatric Cancers - Immunocompromised - Cancer Survivors This Study Provides Evidence That chronic Hepatitis B And/Or C Have An Impact On The Histopathological Outcome Of Liver Disease In Pediatric Cancer Survivors Which May Lead To Progression Of Liver Disease In Patients. Some Chemotherapeutic Agents Are Hepatotoxic Inducing Recurrent Hepatitis Flares In Cancer Patients Infected With Viral Hepatitis Contributing To Liver Dysfunction And Liver Cirrhosis. Therefore Routine Viral Screening Is Mandatory Before, During And At The End Of Treatment For Cancer Patients For Early Detection And Prevention Of Liver Dysfunction. Further Studies With Long-Term Follow-Up Data On Approved Antiviral Therapies Are Required In Cancer Patients With Viral Hepatitis.